NCT02236182View on ClinicalTrials.gov

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

February 28, 1999

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Ipratropium Bromide low dose

DRUG

Placebo

DRUG

Ipratropium Bromide high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY